Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro

Detalhes bibliográficos
Autor(a) principal: Damada, Pedro Henrique
Data de Publicação: 2019
Tipo de documento: Dissertação
Idioma: por
Título da fonte: Repositório Institucional da UFSCAR
Texto Completo: https://repositorio.ufscar.br/handle/ufscar/11683
Resumo: Cancer is one of the deadliest diseases in the world. Its treatment includes surgical, chemotherapeutic and radiotherapeutic methods, which, although efficient, are expensive, long and can have several side effects to the patient. In order to seek new methodologies, immunotherapy, a treatment based on stimulation of the immune system to control cancer, has been one of the most interesting. One of the most used immunotherapeutic methods for this purpose is based on the use of monoclonal antibodies (mAbs), high specificity glycoproteins that are gaining space and arousing interest due to the positive results have already obtained for different diseases, such as multiple sclerosis and breast cancer. The objective of this work was to optimize the culture of PC-61 hybridomas in spinner flask for the production of the anti-CD25 mAb, with serum free commercial medium (SFM) and with RPMI medium supplemented with fetal bovine serum (FBS), used as control. Two modes of operation were used: batch and fed batch, in order to compare the results and propose a better methodology of cultivation. In addition, the purification of the antibodies was done using the techniques of ion exchange chromatography and immunoprecipitation with protein G in Sepharose. As a result, by batch culture, it was possible to identify the behavior of the cells and to stipulate the best conditions to carry out batch culture. Thus, it was possible to prolong the pre-stationary phase of the culture where a higher production of monoclonal antibody was observed. The SFM medium presented the best results compared to RPMI (with FBS) in batch culture, it was found that the production of mAbs in SFM was 3 times higher than in RPMI (with FBS). Furthermore, through these cultures, cells have been noted to direct their metabolism to produce the antibody when the nutrient level in the culture medium is reduced, and stress conditions (without causing cell death) can lead to increased production of antibody. In relation to purification, the immunoprecipitation technique with G protein proved to be very efficient, mainly for the separation of the antibodies present in the supernatant of the SFM culture, which has low protein content. Therefore, the use of the SFM medium is a great alternative to the culture media supplemented with FBS, since, in certain conditions, it allows the obtaining of larger amounts of antibody, and ensures greater ease in the application of purification techniques, reducing production costs.
id SCAR_d97a0799665e746deeee79320f0280f4
oai_identifier_str oai:repositorio.ufscar.br:ufscar/11683
network_acronym_str SCAR
network_name_str Repositório Institucional da UFSCAR
repository_id_str 4322
spelling Damada, Pedro HenriqueAnibal, Fernanda de Freitashttp://lattes.cnpq.br/4918261968772806Suazo, Cláudio Alberto Torreshttp://lattes.cnpq.br/9591447226240450http://lattes.cnpq.br/08736566842063688f221217-77ef-42ee-98ee-a8b60ed705812019-08-09T19:53:07Z2019-08-09T19:53:07Z2019-03-22DAMADA, Pedro Henrique. Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro. 2019. Dissertação (Mestrado em Biotecnologia) – Universidade Federal de São Carlos, São Carlos, 2019. Disponível em: https://repositorio.ufscar.br/handle/ufscar/11683.https://repositorio.ufscar.br/handle/ufscar/11683Cancer is one of the deadliest diseases in the world. Its treatment includes surgical, chemotherapeutic and radiotherapeutic methods, which, although efficient, are expensive, long and can have several side effects to the patient. In order to seek new methodologies, immunotherapy, a treatment based on stimulation of the immune system to control cancer, has been one of the most interesting. One of the most used immunotherapeutic methods for this purpose is based on the use of monoclonal antibodies (mAbs), high specificity glycoproteins that are gaining space and arousing interest due to the positive results have already obtained for different diseases, such as multiple sclerosis and breast cancer. The objective of this work was to optimize the culture of PC-61 hybridomas in spinner flask for the production of the anti-CD25 mAb, with serum free commercial medium (SFM) and with RPMI medium supplemented with fetal bovine serum (FBS), used as control. Two modes of operation were used: batch and fed batch, in order to compare the results and propose a better methodology of cultivation. In addition, the purification of the antibodies was done using the techniques of ion exchange chromatography and immunoprecipitation with protein G in Sepharose. As a result, by batch culture, it was possible to identify the behavior of the cells and to stipulate the best conditions to carry out batch culture. Thus, it was possible to prolong the pre-stationary phase of the culture where a higher production of monoclonal antibody was observed. The SFM medium presented the best results compared to RPMI (with FBS) in batch culture, it was found that the production of mAbs in SFM was 3 times higher than in RPMI (with FBS). Furthermore, through these cultures, cells have been noted to direct their metabolism to produce the antibody when the nutrient level in the culture medium is reduced, and stress conditions (without causing cell death) can lead to increased production of antibody. In relation to purification, the immunoprecipitation technique with G protein proved to be very efficient, mainly for the separation of the antibodies present in the supernatant of the SFM culture, which has low protein content. Therefore, the use of the SFM medium is a great alternative to the culture media supplemented with FBS, since, in certain conditions, it allows the obtaining of larger amounts of antibody, and ensures greater ease in the application of purification techniques, reducing production costs.O câncer é uma das doenças que mais causa mortes no mundo, para seu tratamento se destacam, métodos cirúrgicos, quimioterapêuticos e radioterapêuticos, os quais, nem sempre são eficientes, são de alto custo, de longa duração e podem trazer diversos efeitos adversos ao paciente. Com o intuito buscar novas metodologias, a imunoterapia, tratamento baseado na estimulação do sistema imune para o controle do câncer, tem sido uma das mais interessantes. Um dos métodos imunoterapêuticos mais utilizados é o uso anticorpos monoclonais (mAbs), que são glicoproteínas de alta especificidade, a qual já apresenta resultados positivos para doenças como esclerose múltipla e câncer de mama. Este trabalho teve como objetivo a otimização do cultivo de hibridomas PC-61 em biorreator do tipo spinner para a produção do mAb anti-CD25, com meio comercial livre de soro (SFM - Serum Free Medium) e com meio RPMI, suplementado com soro fetal bovino (SFB), utilizado como controle. Foram utilizados dois modos de operação: batelada e batelada alimentada, a fim de se comparar e propor uma melhor metodologia de cultivo. Além disso, foi feito a purificação desses anticorpos utilizando as técnicas de cromatografia de troca iônica e imunoprecipitação com proteína G em Sepharose. Como resultado, por meio do cultivo em batelada foi possível identificar o comportamento das células e estipular as melhores condições para realizar o cultivo em batelada alimentada. E assim, foi possível prolongar a fase pré-estacionária do cultivo onde observou-se maior produção de anticorpo monoclonal. O meio SFM apresentou os melhores resultados, em comparação ao RPMI (com SFB), no cultivo em batelada, e verificou-se que a produção de mAbs no SFM, foi 3 vezes maior do que no RPMI (com SFB). Além disso, através destes cultivos, notou-se que as células direcionam o seu metabolismo para produzir o anticorpo quando o nível de nutrientes no meio de cultivo é reduzido, e condições de estresse (sem ocasionar a morte celular) podem levar a uma produção maior de anticorpo. Quanto à purificação, a técnica de imunoprecipitação com proteína G se mostrou bastante eficiente, principalmente para a separação dos anticorpos presentes no sobrenadante do cultivo com SFM, que possui baixo teor proteico. Portanto, a utilização do meio SFM é uma ótima alternativa em comparação aos meios de cultivo suplementados com SBF, uma vez que, em determinada condição, permite a obtenção de maiores quantidades de anticorpo, e garante maior facilidade na aplicação de técnicas de purificação, diminuindo os custos da produção.Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)CAPES: 1817237porUniversidade Federal de São CarlosCâmpus São CarlosPrograma de Pós-Graduação em Biotecnologia - PPGBiotecUFSCarImunoterapiaAnticorpo monoclonal anti-CD25Soro fetal bovinoImmunotherapyAnti-CD25 monoclonal antibodyFetal bovine serumCIENCIAS BIOLOGICAS::IMUNOLOGIAENGENHARIAS::ENGENHARIA QUIMICAObtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soroObtaining anti-CD25 murine monoclonal antibody through the cultivation of PC-61 hybridoma in spinner bioreactors in serum free mediuminfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesis12 meses após a data da defesa600600d0b619ca-16cf-40f9-9e9b-1792083fa39finfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UFSCARinstname:Universidade Federal de São Carlos (UFSCAR)instacron:UFSCARORIGINALDissertação - Pedro H Damada.pdfDissertação - Pedro H Damada.pdfapplication/pdf15243754https://repositorio.ufscar.br/bitstream/ufscar/11683/1/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdfada546a95395dc02683d446902a7e6b1MD51LICENSElicense.txtlicense.txttext/plain; charset=utf-81957https://repositorio.ufscar.br/bitstream/ufscar/11683/4/license.txtae0398b6f8b235e40ad82cba6c50031dMD54TEXTDissertação - Pedro H Damada.pdf.txtDissertação - Pedro H Damada.pdf.txtExtracted texttext/plain244758https://repositorio.ufscar.br/bitstream/ufscar/11683/5/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdf.txtc59bcf91a90e85389376f93ae2df5fdaMD55THUMBNAILDissertação - Pedro H Damada.pdf.jpgDissertação - Pedro H Damada.pdf.jpgIM Thumbnailimage/jpeg5290https://repositorio.ufscar.br/bitstream/ufscar/11683/6/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdf.jpg046a3c240f3095b97620c9fdaae4caa0MD56ufscar/116832023-09-18 18:31:54.992oai:repositorio.ufscar.br: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Repositório InstitucionalPUBhttps://repositorio.ufscar.br/oai/requestopendoar:43222023-09-18T18:31:54Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)false
dc.title.por.fl_str_mv Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
dc.title.alternative.eng.fl_str_mv Obtaining anti-CD25 murine monoclonal antibody through the cultivation of PC-61 hybridoma in spinner bioreactors in serum free medium
title Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
spellingShingle Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
Damada, Pedro Henrique
Imunoterapia
Anticorpo monoclonal anti-CD25
Soro fetal bovino
Immunotherapy
Anti-CD25 monoclonal antibody
Fetal bovine serum
CIENCIAS BIOLOGICAS::IMUNOLOGIA
ENGENHARIAS::ENGENHARIA QUIMICA
title_short Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
title_full Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
title_fullStr Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
title_full_unstemmed Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
title_sort Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro
author Damada, Pedro Henrique
author_facet Damada, Pedro Henrique
author_role author
dc.contributor.authorlattes.por.fl_str_mv http://lattes.cnpq.br/0873656684206368
dc.contributor.author.fl_str_mv Damada, Pedro Henrique
dc.contributor.advisor1.fl_str_mv Anibal, Fernanda de Freitas
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/4918261968772806
dc.contributor.advisor-co1.fl_str_mv Suazo, Cláudio Alberto Torres
dc.contributor.advisor-co1Lattes.fl_str_mv http://lattes.cnpq.br/9591447226240450
dc.contributor.authorID.fl_str_mv 8f221217-77ef-42ee-98ee-a8b60ed70581
contributor_str_mv Anibal, Fernanda de Freitas
Suazo, Cláudio Alberto Torres
dc.subject.por.fl_str_mv Imunoterapia
Anticorpo monoclonal anti-CD25
Soro fetal bovino
topic Imunoterapia
Anticorpo monoclonal anti-CD25
Soro fetal bovino
Immunotherapy
Anti-CD25 monoclonal antibody
Fetal bovine serum
CIENCIAS BIOLOGICAS::IMUNOLOGIA
ENGENHARIAS::ENGENHARIA QUIMICA
dc.subject.eng.fl_str_mv Immunotherapy
Anti-CD25 monoclonal antibody
Fetal bovine serum
dc.subject.cnpq.fl_str_mv CIENCIAS BIOLOGICAS::IMUNOLOGIA
ENGENHARIAS::ENGENHARIA QUIMICA
description Cancer is one of the deadliest diseases in the world. Its treatment includes surgical, chemotherapeutic and radiotherapeutic methods, which, although efficient, are expensive, long and can have several side effects to the patient. In order to seek new methodologies, immunotherapy, a treatment based on stimulation of the immune system to control cancer, has been one of the most interesting. One of the most used immunotherapeutic methods for this purpose is based on the use of monoclonal antibodies (mAbs), high specificity glycoproteins that are gaining space and arousing interest due to the positive results have already obtained for different diseases, such as multiple sclerosis and breast cancer. The objective of this work was to optimize the culture of PC-61 hybridomas in spinner flask for the production of the anti-CD25 mAb, with serum free commercial medium (SFM) and with RPMI medium supplemented with fetal bovine serum (FBS), used as control. Two modes of operation were used: batch and fed batch, in order to compare the results and propose a better methodology of cultivation. In addition, the purification of the antibodies was done using the techniques of ion exchange chromatography and immunoprecipitation with protein G in Sepharose. As a result, by batch culture, it was possible to identify the behavior of the cells and to stipulate the best conditions to carry out batch culture. Thus, it was possible to prolong the pre-stationary phase of the culture where a higher production of monoclonal antibody was observed. The SFM medium presented the best results compared to RPMI (with FBS) in batch culture, it was found that the production of mAbs in SFM was 3 times higher than in RPMI (with FBS). Furthermore, through these cultures, cells have been noted to direct their metabolism to produce the antibody when the nutrient level in the culture medium is reduced, and stress conditions (without causing cell death) can lead to increased production of antibody. In relation to purification, the immunoprecipitation technique with G protein proved to be very efficient, mainly for the separation of the antibodies present in the supernatant of the SFM culture, which has low protein content. Therefore, the use of the SFM medium is a great alternative to the culture media supplemented with FBS, since, in certain conditions, it allows the obtaining of larger amounts of antibody, and ensures greater ease in the application of purification techniques, reducing production costs.
publishDate 2019
dc.date.accessioned.fl_str_mv 2019-08-09T19:53:07Z
dc.date.available.fl_str_mv 2019-08-09T19:53:07Z
dc.date.issued.fl_str_mv 2019-03-22
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.citation.fl_str_mv DAMADA, Pedro Henrique. Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro. 2019. Dissertação (Mestrado em Biotecnologia) – Universidade Federal de São Carlos, São Carlos, 2019. Disponível em: https://repositorio.ufscar.br/handle/ufscar/11683.
dc.identifier.uri.fl_str_mv https://repositorio.ufscar.br/handle/ufscar/11683
identifier_str_mv DAMADA, Pedro Henrique. Obtenção de anticorpo monoclonal murino anti-cd25 através do cultivo do hibridoma pc-61 em biorreatores spinner em meio livre de soro. 2019. Dissertação (Mestrado em Biotecnologia) – Universidade Federal de São Carlos, São Carlos, 2019. Disponível em: https://repositorio.ufscar.br/handle/ufscar/11683.
url https://repositorio.ufscar.br/handle/ufscar/11683
dc.language.iso.fl_str_mv por
language por
dc.relation.confidence.fl_str_mv 600
600
dc.relation.authority.fl_str_mv d0b619ca-16cf-40f9-9e9b-1792083fa39f
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.publisher.program.fl_str_mv Programa de Pós-Graduação em Biotecnologia - PPGBiotec
dc.publisher.initials.fl_str_mv UFSCar
publisher.none.fl_str_mv Universidade Federal de São Carlos
Câmpus São Carlos
dc.source.none.fl_str_mv reponame:Repositório Institucional da UFSCAR
instname:Universidade Federal de São Carlos (UFSCAR)
instacron:UFSCAR
instname_str Universidade Federal de São Carlos (UFSCAR)
instacron_str UFSCAR
institution UFSCAR
reponame_str Repositório Institucional da UFSCAR
collection Repositório Institucional da UFSCAR
bitstream.url.fl_str_mv https://repositorio.ufscar.br/bitstream/ufscar/11683/1/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdf
https://repositorio.ufscar.br/bitstream/ufscar/11683/4/license.txt
https://repositorio.ufscar.br/bitstream/ufscar/11683/5/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdf.txt
https://repositorio.ufscar.br/bitstream/ufscar/11683/6/Dissertac%cc%a7a%cc%83o%20-%20Pedro%20H%20Damada.pdf.jpg
bitstream.checksum.fl_str_mv ada546a95395dc02683d446902a7e6b1
ae0398b6f8b235e40ad82cba6c50031d
c59bcf91a90e85389376f93ae2df5fda
046a3c240f3095b97620c9fdaae4caa0
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da UFSCAR - Universidade Federal de São Carlos (UFSCAR)
repository.mail.fl_str_mv
_version_ 1813715607201251328